Publications - Page 43 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 02/08/23
Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure

Savale L, Vuillard C, Pichon J, Boucly A, Roche A, Jevnikar M, Ebstein N, Jaïs X, Le Pavec J, Montani D, Mercier O, Sitbon O, Fadel E, Humbert M.

Eur Respir J. 2021 Sep 23;58(3):2100466. Doi: 10.1183/13993003.00466-2021.
Sarcoïdose 02/08/23
Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis

Pastré J, Bouvry D, Juvin K, Benattia A, Annesi-Maesano I, Valeyre D, Nunes H, Israël-Biet D.

J Clin Med. 2021 May 5;10(9):1988. Doi: 10.3390/jcm10091988.
Sarcoïdose 02/08/23
Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort

Lhote R, Annesi-Maesano I, Nunes H, Launay D, Borie R, Sacré K, Schleinitz N, Hamidou M, Mahevas M, Devilliers H, Bonniaud P, Lhote F, Haroche J, Rufat P, Amoura Z, Valeyre D, Cohen Aubart F.

Eur Respir J. 2021 Apr 1;57(4):2001160. Doi: 10.1183/13993003.01160-2020.
Hypertension pulmonaire (HTP) 02/08/23
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Duflot T, Tu L, Leuillier M, Messaoudi H, Groussard D, Feugray G, Azhar S, Thuillet R, Bauer F, Humbert M, Richard V, Guignabert C, Bellien J.

Metabolites. 2021 Nov 17;11(11):784.
Hypertension pulmonaire (HTP) 02/08/23
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload

Lambert M, Mendes-Ferreira P, Ghigna MR, LeRibeuz H, Adão R, Boet A, Capuano V, Rucker-Martin C, Brás-Silva C, Quarck R, Domergue V, Vachiéry JL, Humbert M, Perros F, Montani D, Antigny F.

Cardiovasc Res. 2021 Nov 1;117(12):2474-2488.
Hypertension pulmonaire (HTP) 02/08/23
External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry

Boucly A, Weatherald J, Savale L, de Groote P, Cottin V, Prévot G, Chaouat A, Picard F, Horeau-Langlard D, Bourdin A, Jutant EM, Beurnier A, Jevnikar M, Jaïs X, Simonneau G, Montani D, Sitbon O, Humbert M.

Eur Respir J. 2021 Nov 4:2102419.
Fibrose pulmonaire - FPI 28/07/23
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden

Lancaster L, Bonella F, Inoue Y, Cottin V, Siddall J, Small M, Langley J.

Respirology. 2021 Oct 5. Doi: 10.1111/resp.14154.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure

Sarcoidosis-Like Cancer-Associated Granulomatosis: Characteristics and a Case-Control Comparison with Sarcoidosis

Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload

External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry

Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden